Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹64.8 Cr -2.5% -12% -61.1% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,117.5 Cr 2.6% -2.7% -15.9% Stock Analytics
KIRI INDUSTRIES ₹2,788.1 Cr 1.3% -24.3% -14.4% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,562.0 Cr -1.4% -7.5% -37% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,060.5 Cr -3.6% -12.4% 18.8% Stock Analytics
BODAL CHEMICALS ₹603.3 Cr 1.8% -9.9% -22.6% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-2.5%

-12%

-61.1%

SENSEX

-0.1%

-2.9%

7.5%


You may also like the below Video Courses